Related Experiment Video

Updated: Aug 13, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

PML a target of translocations in APL is a regulator of cellular senescence

G Ferbeyre1

  • 1Université de Montréal, Département de Biochimie, Canada.

Leukemia
|October 3, 2002
PubMed

Insights

Acute promyelocytic leukemia (APL) involves PML-RARalpha fusion proteins that block cell differentiation and senescence. Effective APL treatments work by restoring the senescence program, crucial for tumor suppression and cell differentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Acute promyelocytic leukemia (APL) is characterized by PML-RARalpha fusion proteins.
  • These proteins are implicated in blocking cell differentiation and disrupting nuclear body function.
  • PML is also a regulator of replicative and oncogene-induced senescence.

Purpose of the Study:

  • To review the role of senescence as a tumor suppressor mechanism in APL and other cancers.
  • To explore how PML-RARalpha fusion protein contributes to leukemogenesis by interfering with senescence.
  • To discuss the mechanism of action for retinoids and other APL drugs in re-establishing senescence.

Main Methods:

  • Literature review of studies on PML, RARalpha, APL, and senescence.
  • Analysis of proposed models for APL pathogenesis.
  • Discussion of the interplay between PML, senescence, and cell differentiation.

Main Results:

  • Senescence is presented as a general tumor suppressor mechanism linked to terminal differentiation.
  • PML-RARalpha fusion protein disrupts senescence by repressing retinoic acid responsive genes and interfering with tumor suppressor proteins.
  • Therapeutic agents for APL restore the senescence program, which encompasses differentiation features.

Conclusions:

  • Senescence is a critical tumor suppressor pathway disrupted in APL.
  • PML-RARalpha fusion protein's oncogenic activity stems from its interference with senescence.
  • Restoring senescence is a key therapeutic strategy for APL.

More Related Videos

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays11:05

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Published on: January 7, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...